| Results of Meeting | Nov 4, 2026 | Meeting outcome | ASX |
|---|
| Chair's Address to Shareholders and CEO presentation | Nov 3, 2026 | Meeting outcome | ASX |
|---|
| PCK AGM watching the live feed | Nov 1, 2026 | Meeting notice | ASX |
|---|
| Final Director's Interest Notice | Oct 30, 2026 | Ownership change notice | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 27, 2026 | Quarterly report | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 27, 2026 | Quarterly report | ASX |
|---|
| PainChek wins 1,800-licence UK contract with Hallmark | Oct 26, 2026 | Operations update | ASX |
|---|
| John Murray retires as PainChek non-executive director | Oct 25, 2026 | Management or board change | ASX |
|---|
| Notification regarding unquoted securities - PCK | Oct 12, 2026 | Other filings | ASX |
|---|
| PainChek expands Sabra contracts to 23 US communities | Oct 12, 2026 | Operations update | ASX |
|---|
| Change of Director's Interest Notice x3 | Sep 30, 2026 | Ownership change notice | ASX |
|---|
| Application for quotation of securities - PCK | Sep 30, 2026 | Financing | ASX |
|---|
| Notice of Annual General Meeting/Proxy Form | Sep 29, 2026 | Meeting notice | ASX |
|---|
| Corporate Governance Statement and Appendix 4G 2026 | Sep 22, 2026 | Other filings | ASX |
|---|
| Annual Report to shareholders | Sep 22, 2026 | Annual report | ASX |
|---|
| Final Director's Interest Notice | Sep 7, 2026 | Ownership change notice | ASX |
|---|
| Investor Webinar Invite | Sep 2, 2026 | Other filings | ASX |
|---|
| Resignation of Non-Executive Director | Sep 2, 2026 | Management or board change | ASX |
|---|
| Appendix 4E and Financial Report | Aug 28, 2026 | Results | ASX |
|---|
| PainChek Investor Webinar | Aug 6, 2026 | Other filings | ASX |
|---|
| Update - Notification regarding unquoted securities - PCK | Aug 5, 2026 | Other filings | ASX |
|---|
| Change of Director's Interest Notice x 4 | Aug 5, 2026 | Ownership change notice | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Jul 28, 2026 | Quarterly report | ASX |
|---|
| PainChek receives $1.123 million R&D tax incentive refund | Jul 21, 2026 | Results | ASX |
|---|
| US MedTech leader Karen Holzberger appointed CEO | Jul 19, 2026 | Other filings | ASX |
|---|
| CEO Transition | Jul 6, 2026 | Other filings | ASX |
|---|
| PainChek secures A$5.5m note to fund US expansion | May 21, 2026 | Financing | ASX |
|---|
| Landmark Sabra North America deployment targeting 20k beds | Apr 13, 2026 | Operations update | ASX |
|---|
| PainChek reports material sales momentum in UK | Mar 25, 2026 | Operations update | ASX |
|---|
| Half Yearly Report and Accounts | Feb 27, 2026 | Interim report | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Jan 29, 2026 | Quarterly report | ASX |
|---|
| PainChek Business Update | Jan 29, 2026 | Operations update | ASX |
|---|
| PainChek gains access to RTM reimbursement in USA | Jan 28, 2026 | Operations update | ASX |
|---|
| AGM Presentation | Nov 25, 2025 | Meeting notice | ASX |
|---|
| Investor Presentation | Oct 30, 2025 | Other filings | ASX |
|---|
| Notice of Annual General Meeting/Proxy Form | Oct 24, 2025 | Meeting notice | ASX |
|---|
| Key hire to drive Infant App in $15Bn addressable market | Oct 16, 2025 | Management or board change | ASX |
|---|
| Response to ASX Aware Letter | Oct 16, 2025 | Explanation request | ASX |
|---|
| PainChek Secures First US Customer Following FDA Clearance | Oct 12, 2025 | Operations update | ASX |
|---|
| PainChek FDA Cleared to Commence Sales in US$100M US Market | Oct 8, 2025 | Operations update | ASX |
|---|
| Trading Halt | Oct 6, 2025 | Trading halt or suspension | ASX |
|---|
| Compelling Clinical and Economic Results in Scottish Pilot | Sep 16, 2025 | Operations update | ASX |
|---|
| Preliminary Final Report | Aug 28, 2025 | Results | ASX |
|---|
| Strongly Supported A$7.5m Placement to Drive Int. Growth | Jul 28, 2025 | Financing | ASX |
|---|
| Final US FDA De Novo Clearance Submission Completed | Jul 20, 2025 | Operations update | ASX |
|---|
| PainChek Reports Strong Quarterly Sales Growth | Jul 2, 2025 | Quarterly report | ASX |
|---|
| PainChek has productive final FDA De Novo clearance meeting | Jun 4, 2025 | Operations update | ASX |
|---|
| PainChek partners with Eldermark to expand US market reach | May 26, 2025 | Other filings | ASX |
|---|
| R&D Tax Refund, FDA Review of Adult App & Infant App Launch | Apr 15, 2025 | Other filings | ASX |
|---|
| PainChek completes Entitlement Offer raising AUD $5.1 m | Dec 16, 2024 | Financing | ASX |
|---|
| PainChek Implementations, Market and International Expansion | Dec 10, 2024 | Operations update | ASX |
|---|
| Prospectus | Nov 24, 2024 | Offer document | ASX |
|---|
| Underwritten Entitlement Offer to raise AUD $5.1million | Nov 24, 2024 | Financing | ASX |
|---|
| PCK submits application for Adult App FDA De Novo clearance | Nov 19, 2024 | Other filings | ASX |
|---|
| PCK expands market reach with BESTMED reseller agreement | Nov 12, 2024 | Operations update | ASX |
|---|
| Positive study results pave way for PainChek FDA submission | Oct 28, 2024 | Other filings | ASX |
|---|
| PainChek Adult app FDA De Novo submission update | Oct 1, 2024 | Operations update | ASX |
|---|
| PainChek receives European patent for pain assessment tech | May 27, 2024 | Other filings | ASX |
|---|
| PainChek receives $1,210,000 R&D Tax Incentive Refund | Apr 22, 2024 | Other filings | ASX |
|---|
| PainChek UK partnership with Nourish Care | Mar 13, 2024 | Operations update | ASX |
|---|
| PainChek completes A$5m capital raise | Mar 13, 2024 | Financing | ASX |
|---|
| PainChek Share Purchase Plan oversubscribed | Mar 6, 2024 | Financing | ASX |
|---|
| Underwritten Share Purchase Plan to raise AUD $2.5 million | Feb 13, 2024 | Financing | ASX |
|---|
| Notice of Acceptance for European Patent | Nov 20, 2023 | Other filings | ASX |
|---|
| Quarterly Update and Appendix 4C | Oct 30, 2023 | Quarterly report | ASX |
|---|
| Response to ASX Price Query | Oct 9, 2023 | Explanation request | ASX |
|---|
| PainChek A$3.55m Placement | Sep 14, 2023 | Financing | ASX |
|---|
| US nursing home study to pave way for FDA De Novo clearance | Aug 24, 2023 | Operations update | ASX |
|---|
| PainChek receives $1.049m R&D Tax Incentive Refund | Jul 24, 2023 | Other filings | ASX |
|---|
| Ethos Laboratories Distribution Agreement | Jun 15, 2023 | Other filings | ASX |
|---|
| AGM CEO Presentation | Nov 22, 2022 | Other filings | ASX |
|---|
| Response to ASX Query | Sep 30, 2022 | Explanation request | ASX |
|---|
| PCK expands activities to Japan with JETRO business connect | Sep 25, 2022 | Other filings | ASX |
|---|
| Financial Statements 30 June 2022 & Appendix 4E | Aug 31, 2022 | Results | ASX |
|---|
| Results of Non-Renounceable Entitlement Offer | Jul 29, 2022 | Financing | ASX |
|---|
| PCK receives funding for 12 month pilot in Welsh care homes | Jul 26, 2022 | Other filings | ASX |
|---|
| PCK to receive Govt funding for childrens disability app | Jul 5, 2022 | Other filings | ASX |
|---|
| Offer Booklet | Jul 4, 2022 | Offer document | ASX |
|---|
| Equity Raising & Results of Placement | Jun 24, 2022 | Financing | ASX |
|---|
| Quarterly Investor Update Presentation | May 2, 2022 | Other filings | ASX |
|---|
| Summerset Holdings Ltd rolls out PainChek in NZ | Mar 27, 2022 | Other filings | ASX |
|---|
| Appendix 4D and Half Year Report | Feb 27, 2022 | Interim report | ASX |
|---|
| Quarterly Update Investor Presentation | Jan 28, 2022 | Other filings | ASX |
|---|
| Response to ASX Price and Volume Query | Nov 29, 2021 | Explanation request | ASX |
|---|
| September Quarterly Update | Oct 21, 2021 | Other filings | ASX |
|---|
| Appendix 4C Cash Flow Report | Oct 21, 2021 | Quarterly report | ASX |
|---|
| Quarterly Update June 2021 | Jul 28, 2021 | Other filings | ASX |
|---|
| Appendix 4C | Jul 28, 2021 | Quarterly report | ASX |
|---|
| PainChek to receive $1.25M milestone payment from DoH | Jun 27, 2021 | Other filings | ASX |
|---|
| PainChek Infant Achieves International Regulatory Clearances | May 19, 2021 | Other filings | ASX |
|---|
| Appendix 4C - quarterly | Apr 28, 2021 | Quarterly report | ASX |
|---|
| March 2021 Quarterly Update | Apr 28, 2021 | Other filings | ASX |
|---|
| PainChek receives CE Mark & TGA clearance for Universal App | Mar 16, 2021 | Other filings | ASX |
|---|
| S&P DJI Announces March 2021 Quarterly Rebalance | Mar 12, 2021 | Other filings | ASX |
|---|
| Appendix 4D & Financial Statements | Feb 25, 2021 | Interim report | ASX |
|---|
| Presentation - December 2020 Quarter Update | Jan 21, 2021 | Other filings | ASX |
|---|
| December 2020 Quarterly Update | Jan 21, 2021 | Other filings | ASX |
|---|
| PainChek receives regulatory clearance from Health Canada | Nov 18, 2020 | Other filings | ASX |
|---|
| New Zealand expansion through Medi-map partnership | Nov 1, 2020 | Other filings | ASX |
|---|
| September 2020 Quarterly Update | Oct 30, 2020 | Other filings | ASX |
|---|
| AlayaCare to partner PCK in Canadian Home Care Market | Oct 27, 2020 | Other filings | ASX |
|---|
| Partnership with Nulsen Group for Disability Pain Management | Oct 22, 2020 | Other filings | ASX |
|---|
| Partnership with Ramsay & ECU for Hospital Pain Management | Oct 1, 2020 | Other filings | ASX |
|---|
| Proposed issue of Securities - PCK | Aug 10, 2020 | Financing | ASX |
|---|
| June 2020 Quarterly Update | Jul 27, 2020 | Other filings | ASX |
|---|
| S&P DJI Announces June 2020 Quarterly Rebalance | Jun 11, 2020 | Other filings | ASX |
|---|
| 50% growth in beds, clients & facilities in March quarter | Apr 29, 2020 | Other filings | ASX |
|---|
| 25,000 Govt Bed Milestone Achieved, Triggers $1.25m Payment | Mar 18, 2020 | Other filings | ASX |
|---|
| PainChek receives $798,000 R&D Tax Incentive | Feb 2, 2020 | Other filings | ASX |
|---|
| Update on PainChek Business Performance | Dec 22, 2019 | Other filings | ASX |
|---|
| DACS Grant Funding Contract for National Trial Signed | Dec 3, 2019 | Other filings | ASX |
|---|
| Quarterly Update | Oct 30, 2019 | Other filings | ASX |
|---|
| Singapore Regulatory Clearance Received. Allium Agreement | Aug 5, 2019 | Other filings | ASX |
|---|
| PainChek Partners with MCRI for Infant App PainFaces Study | Jul 1, 2019 | Other filings | ASX |
|---|
| $4.15M Placement to Fast-Track International Expansion | Jun 18, 2019 | Financing | ASX |
|---|
| International Market Milestone Achieved with UK Distribution | May 26, 2019 | Other filings | ASX |
|---|
| Morrison Govt $5M Grant for PainChek Trial in Aged Care | Apr 29, 2019 | Other filings | ASX |
|---|
| Pause in Trading | Apr 26, 2019 | Trading halt or suspension | ASX |
|---|
| Churches of Christ License PCK for 1,000 RAC Beds | Apr 8, 2019 | Other filings | ASX |
|---|
| Agreement with Leecare Solutions | Oct 2, 2018 | Other filings | ASX |
|---|
| Allity Aged Care partners with PainChek | Sep 9, 2018 | Other filings | ASX |
|---|
| Investor Update | Jul 30, 2018 | Other filings | ASX |
|---|
| National roll out with DSA follows successful pilot | Jun 13, 2018 | Other filings | ASX |
|---|
| New publication confirms accuracy of PainChek(R) | Jun 6, 2018 | Other filings | ASX |
|---|
| PainChek receives FDA regulatory guidance | May 9, 2018 | Guidance | ASX |
|---|
| Agreement signed with leading software system provider | Mar 27, 2018 | Other filings | ASX |
|---|
| Half Year Report and Financial Statements | Feb 23, 2018 | Interim report | ASX |
|---|
| PainChek App Android version now in beta testing | Jan 29, 2018 | Other filings | ASX |
|---|
| New Peer reviewed published study | Jan 28, 2018 | Other filings | ASX |
|---|
| 2nd peer-review confirms excellent performance of PainChek | Dec 12, 2017 | Other filings | ASX |
|---|
| ePAT and PainChek continue to achieve commercial milestones | Nov 8, 2017 | Other filings | ASX |
|---|
| Placement to raise $3.75 million | Sep 17, 2017 | Financing | ASX |
|---|
| Core strategic agreement with Dementia Support Australia | Sep 6, 2017 | Other filings | ASX |
|---|
| ePAT Clinical Study Published in Alzheimers Disease Journal | Aug 15, 2017 | Other filings | ASX |
|---|
| nViso agrees perpetual global license, takes strategic stake | Jul 24, 2017 | Other filings | ASX |
|---|
| ePAT Pain Assessment App Secures Regulatory Clearance | Jul 18, 2017 | Other filings | ASX |
|---|
| New Study Validates Face Recognition App in Pain Detection | Jul 3, 2017 | Other filings | ASX |
|---|
| Launch of IBM Case Study | Mar 15, 2017 | Other filings | ASX |
|---|
| Second Quarter Report FY 2016/17 | Jan 30, 2017 | Other filings | ASX |
|---|
| Market Update | Dec 14, 2016 | Other filings | ASX |
|---|
| Quarterly Review and Appendix 4C | Dec 9, 2016 | Quarterly report | ASX |
|---|
| Suspension from Official Quotation | Jul 18, 2016 | Trading halt or suspension | ASX |
|---|
| MinQuest completes interim capital raising | Jul 17, 2016 | Financing | ASX |
|---|
| ePAT Signs MOU with UK Insurance Counter-Fraud Group | Jun 15, 2016 | Other filings | ASX |
|---|
| Update on ePAT for Infant Apps | Jun 1, 2016 | Other filings | ASX |
|---|
| ePAT to commence test of new version of dementia App | May 25, 2016 | Other filings | ASX |
|---|
| ePAT validation tests successful | May 18, 2016 | Other filings | ASX |
|---|
| ePAT Acquisition Update - Completion of Due Diligence | May 9, 2016 | Acquisition or disposal | ASX |
|---|
| Response to Price Query | May 3, 2016 | Explanation request | ASX |
|---|
| Quarterly Activities Report and Quarterly Cashflow Report | Apr 29, 2016 | Quarterly report | ASX |
|---|
| Reinstatement to Official Quotation | Apr 22, 2016 | Trading halt or suspension | ASX |
|---|
| Completion of Interim Capital Raising and repayment of Magna | Apr 21, 2016 | Financing | ASX |
|---|
| MNQ to acquire ground-breaking pain management app developer | Apr 13, 2016 | Acquisition or disposal | ASX |
|---|
| Updated on bid for Wolverine zinc mine | Mar 30, 2016 | Other filings | ASX |
|---|
| Marg Scoping Study confirms potentially viable project | Feb 11, 2016 | Other filings | ASX |
|---|
| MinQuest agrees amended terms for Convertible Loan Facility | Feb 10, 2016 | Other filings | ASX |
|---|